Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
JAMA Cardiology|July 21, 2016
Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus InfectionMarkella V Zanni, Mabel Toribio, Gregory K Robbins, et al.
JMIR Formative Research|June 24, 2022
Identifying Patients With Delirium Based on Unstructured Clinical Notes: Observational StudyWendong Ge, Haitham Alabsi, Aayushee Jain, et al.
Plos One|February 10, 2023
Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virusSamer Gawrieh, Kathleen E Corey, Jordan E Lake, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 28, 2025
Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of LifeThiago S Torres, Pooja T Saha, Laura Smeaton, et al.
Nature Medicine|July 15, 2009
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1Angela Meier, J Judy Chang, Ellen S Chan, et al.
Plos One|March 29, 2007
Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infectionMarylyn M Addo, Rika Draenert, Almas Rathod, et al.
Plos Medicine|December 30, 2006
Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfectionArthur Y Kim, Julian Schulze zur Wiesch, Thomas Kuntzen, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
The Journal of Infectious Diseases|February 6, 2008
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitroKersten K Koelsch, Lin Liu, Richard Haubrich, et al.
Gastroenterology|September 30, 2010
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopesArthur Y Kim, Thomas Kuntzen, Joerg Timm, et al.
Pageof 12